<DOC>
	<DOCNO>NCT00093158</DOCNO>
	<brief_summary>The purpose study show , compare heparin ( enoxaparin unfractionated heparin ) routine GPIIb/IIIa inhibition ( either start upfront time percutaneous coronary intervention [ PCI ] ; Arm A ) : 1 . Bivalirudin routine GPIIb/IIIa inhibition ( either start upfront time PCI ; Arm B ) provide non-inferior superior overall clinical outcome 2 . Bivalirudin alone ( Arm C ) reduce clinically significant bleeding . An important secondary objective comparison show bivalirudin inferior ischemic complication .</brief_summary>
	<brief_title>Comparison Angiomax Versus Heparin Acute Coronary Syndromes ( ACS )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . Be age &gt; =18 year time randomization . 2 . Have symptom include least 10 minute angina anginal equivalent investigator believe high likelihood ischemic origin within 24 hour prior randomization consistent diagnosis Unstable Angina/NonST Elevation Myocardial Infarction ( UA/NSTEMI ) ( patient symptoms atypical cardiac ischemia enrol ) . 3 . Meet least one follow criterion UA/NSTEMI : 1 . All follow four feature : *Age &gt; = 65 year ; *aspirin take within last 7 day ; *two episodes angina last 24 hour ; *three follow risk factor : hypertension , high cholesterol , family history , diabetes , current smoker OR 2 . ECG change : New presumably new STsegment depression &gt; =0.1 MV ( &gt; =1mm ) , transient ( &lt; 30 minute ) STsegment elevation &gt; =0.1MV ( &gt; =1mm ) least 2 contiguous lead , OR 3 . Abnormal cardiac enzyme within 24 hour enrollment define elevated troponin I , T creatine phosphokinaseMB isoenzyme ( CPKMB ) level great site 's upper limit normal ( ULN ) OR 4 . History coronary artery disease documentation one following : *prior angiography ( coronary stenosis &gt; 50 % ) ; *prior PCI Coronary Artery Bypass Grafting ( CABG ) ; *prior definite , document myocardial infarction . 4 . Provide write informed consent initiation study related procedure . 1 . Anticipated inability perform angiography within 72 hour randomization anticipate inability perform intervention require ( PCI CABG ) within index hospitalization . 2 . ST segment elevation &gt; 1 mm 2 contiguous ECG lead last &gt; 30 minute , new leave bundle branch block , clinical syndrome consistent acute evolve transmural MI require immediate thrombolytic interventional reperfusion therapy . 3 . Cardiogenic shock ( systolic blood pressure &lt; 80 mmHg &gt; 30 minute respond intravenous fluid , require intravenous pressor agent intraaortic balloon pump ) . 4 . Bleeding diathesis history hemorrhagic stroke intracerebral bleed , cerebral arteriovenous malformation , cerebral aneurysm prior ischemic stroke within last 2 year , prior stroke residual neurologic deficit . Gastrointestinal genitourinary bleeding within last 2weeks . 5 . Platelet count &lt; 100,000 cells/mm3 baseline , history heparin induce thrombocytopenia 6 . Patients warfarin phenprocoumon , unless safely discontinue baseline INR &lt; 1.5 time control . 7 . Allergy pork pork product . 8 . Patients start receive 2 dos low molecular weight heparin current admission prior randomization ( patient receive one dose low molecular weight heparin may still enrol . 9 . Patients start bivalirudin 6 hour prior randomization 10 . Thrombolytic therapy abciximab use within last 24 hour . 11 . Treatment GPIIb/IIIa inhibitor time randomization , discontinue . 12 . Patients Arixtra ( fondaparinux ) . 13 . Absolute contraindication allergy : one enoxaparin , unfractionated heparin , bivalirudin aspirin abciximab eptifibatide eptifibatide tirofiban iodinate contrast premedicated 14 . Contraindications angiography , include limit severe peripheral vascular disease . 15 . Angina secondary cause . 16 . Pregnancy nurse mother . Women child bear potential must negative urine serum pregnancy test prior enrollment . 17 . Calculated serum creatinine clearance &lt; 30 mL/min ( Determined Cockcroft Gault formula : ( ( 140age yr ) x weight kg ) / ( 814.464 x Creatinine mmol/l ) / ( 72 x [ Creatinine mg/dL ] ) . For woman , multiply 0.85 . 18 . Previous enrollment study . 19 . Patients currently enrol another investigational drug study complete followup phase .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Acute Coronary Syndromes</keyword>
</DOC>